Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.
Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.
复制标题
与氟喹诺酮耐药艰难梭菌相关的艰难梭菌感染肠道炎症水平升高。
DOI:
10.1016/j.jhin.2009.05.013
复制
发表时间:
2009
期刊:
影响因子:
--
通讯作者:
Guerrant,RL
中科院分区:
文献类型:
--
作者:
Pawlowski,SW;Archbald-Pannone,L;Carman,RJ;Alcantara-Warren,C;Lyerly,D;Genheimer,CW;Gerding,DN;Guerrant,RL
The Clostridium difficile restriction endonuclease analysis (REA) type BI [polymerase chain reaction (PCR) ribotype 027] strain, with cdtA/cdtB (genes for binary toxin CDT), an 18 bp tcdC deletion, elevated toxin A and B concentrations, and fluoroquinolone resistance, is possibly responsible for the increased Clostridium difficile infection (CDI) incidence, severity, and mortality observed recently. 1–4 The historic BI strain, present at least since the early 1980s also contained the 18 bp deletion, cdtA/cdtB, and levofloxacin resistance, but has not previously been associated with outbreaks. 5 The recent BI strain, however, has additionally acquired resistance to moxifloxacin and gatifloxacin. 5From 2002 to 2005, the number of cases of CDI at the University of Virginia Hospital (UVH) doubled and cases associated with ciprofloxacin use increased (LAP, personal communication). Previous work showed that high levels of fecal lactoferrin, a marker of leucocytes and intestinal inflammation, were associated with moderate to severe clinical CDI. 6 Therefore, our aim was to determine whether the BI strain was present at UVH, and if there was a correlation between genotype, strain type, or moxifloxacin resistance patterns, and lactoferrin levels.